UK markets closed
  • FTSE 100

    6,915.75
    -26.47 (-0.38%)
     
  • FTSE 250

    22,251.26
    +3.72 (+0.02%)
     
  • AIM

    1,236.50
    -2.54 (-0.21%)
     
  • GBP/EUR

    1.1517
    -0.0005 (-0.05%)
     
  • GBP/USD

    1.3706
    -0.0029 (-0.21%)
     
  • BTC-GBP

    43,351.52
    +525.44 (+1.23%)
     
  • CMC Crypto 200

    1,235.89
    +8.34 (+0.68%)
     
  • S&P 500

    4,128.80
    +31.63 (+0.77%)
     
  • DOW

    33,800.60
    +297.03 (+0.89%)
     
  • CRUDE OIL

    59.34
    -0.26 (-0.44%)
     
  • GOLD FUTURES

    1,744.10
    -14.10 (-0.80%)
     
  • NIKKEI 225

    29,768.06
    +59.08 (+0.20%)
     
  • HANG SENG

    28,698.80
    -309.27 (-1.07%)
     
  • DAX

    15,234.16
    +31.48 (+0.21%)
     
  • CAC 40

    6,169.41
    +3.69 (+0.06%)
     

Global Cloud Storage Market to Reach $204.4 Billion by 2027

ReportLinker
·28-min read

Project Details: - StrategyR - A Trademark of Global Industry Analysts, Inc. - Project Edition: 9. - Influencer Pool: 2352. - MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies.

New York, March 30, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Clinical Decision Support Systems Industry" - https://www.reportlinker.com/p06040513/?utm_source=GNW
In addition to being a global intelligence exchange platform, MarketGlass™ is a powerful knowledge center that delivers dynamic project-focused market intelligence. Client companies will have complete insider access to the project Data stack.
- Interactive peer-to-peer and enterprise-to-enterprise ideation and market intelligence exchange is facilitated via a robust, secure, and validated process. The process draws from uniquely qualified project-specific and geographically focused executives overseeing business development, marketing and sales operations.

  • Trends & Factors - Identifying and validating local trends and factors driving each competitive marketplace. These factors include pricing variances, market trajectories, Covid-19 impact and recovery, locally active leading brands, and other parameters impacting the region in the short to medium term such as supply chain realignments.

  • Mobile Access & App - Our mobile version of the report may be accessed via our mobile app or directly for a full mobile experience.

  • Complimentary Updates - for one year. At least one update in 12-month period is normal and anytime there’s a significant change affecting the market dynamics.

  • Bespoke Updates & Team Collaborations - Clients may build a bespoke version of our report with peers on our MarketGlass™ platform which enables multidimensional data simulations.

  • Knowledge Center - clients have full-stack data access for project data they support or purchase including primary research engagement stats, companies and executives.

Abstract:
- Global Clinical Decision Support Systems Market to Reach $2.2 Billion by 2027
- Amid the COVID-19 crisis, the global market for Clinical Decision Support Systems estimated at US$1.1 Billion in the year 2020, is projected to reach a revised size of US$2.2 Billion by 2027, growing at a CAGR of 10.4% over the analysis period 2020-2027. Hardware, one of the segments analyzed in the report, is projected to record a 9.3% CAGR and reach US$669.5 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Software segment is readjusted to a revised 13.1% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $322 Million, While China is Forecast to Grow at 9.8% CAGR
- The Clinical Decision Support Systems market in the U.S. is estimated at US$322 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$375.7 Million by the year 2027 trailing a CAGR of 9.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.7% and 8.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR.
- Services Segment to Record 9.6% CAGR
- In the global Services segment, USA, Canada, Japan, China and Europe will drive the 9.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$380 Million in the year 2020 will reach a projected size of US$725.3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$253.1 Million by the year 2027.

- Select Competitors (Total 43 Featured) -

  • Allscripts Healthcare Solutions, Inc.

  • Cerner Corporation

  • Elsevier BV

  • Epic Systems Corporation

  • Hearst Health

  • IBM Corporation

  • McKesson Corporation

  • MEDITECH

  • Philips Healthcare

  • Wolters Kluwer Health




Read the full report: https://www.reportlinker.com/p06040513/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Clinical Decision
Support Systems by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 2: World Historic Review for Clinical Decision Support
Systems by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 3: World 15-Year Perspective for Clinical Decision
Support Systems by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Hardware by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 5: World Historic Review for Hardware by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Hardware by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 7: World Current & Future Analysis for Software by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 8: World Historic Review for Software by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Software by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 10: World Current & Future Analysis for Services by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 11: World Historic Review for Services by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Services by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 13: World Current & Future Analysis for Cloud-based by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 14: World Historic Review for Cloud-based by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Cloud-based by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for On-premise by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 17: World Historic Review for On-premise by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for On-premise by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Standalone CDSS
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 20: World Historic Review for Standalone CDSS by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 21: World 15-Year Perspective for Standalone CDSS by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Integrated CDSS
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 23: World Historic Review for Integrated CDSS by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 24: World 15-Year Perspective for Integrated CDSS by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Conventional CDSS
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 26: World Historic Review for Conventional CDSS by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 27: World 15-Year Perspective for Conventional CDSS by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 28: World Current & Future Analysis for Advanced CDSS by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 29: World Historic Review for Advanced CDSS by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 30: World 15-Year Perspective for Advanced CDSS by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 31: World Current & Future Analysis for Therapeutic CDSS
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 32: World Historic Review for Therapeutic CDSS by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 33: World 15-Year Perspective for Therapeutic CDSS by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 34: World Current & Future Analysis for Diagnostic CDSS
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 35: World Historic Review for Diagnostic CDSS by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 36: World 15-Year Perspective for Diagnostic CDSS by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 37: USA Current & Future Analysis for Clinical Decision
Support Systems by Component - Hardware, Software and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 38: USA Historic Review for Clinical Decision Support
Systems by Component - Hardware, Software and Services Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 39: USA 15-Year Perspective for Clinical Decision Support
Systems by Component - Percentage Breakdown of Value Sales for
Hardware, Software and Services for the Years 2012, 2020 & 2027

Table 40: USA Current & Future Analysis for Clinical Decision
Support Systems by Delivery mode - Cloud-based and On-premise -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 41: USA Historic Review for Clinical Decision Support
Systems by Delivery mode - Cloud-based and On-premise Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 42: USA 15-Year Perspective for Clinical Decision Support
Systems by Delivery mode - Percentage Breakdown of Value Sales
for Cloud-based and On-premise for the Years 2012, 2020 & 2027

Table 43: USA Current & Future Analysis for Clinical Decision
Support Systems by Product - Standalone CDSS and Integrated
CDSS - Independent Analysis of Annual Sales in US$ Thousand for
the Years 2020 through 2027 and % CAGR

Table 44: USA Historic Review for Clinical Decision Support
Systems by Product - Standalone CDSS and Integrated CDSS
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 45: USA 15-Year Perspective for Clinical Decision Support
Systems by Product - Percentage Breakdown of Value Sales for
Standalone CDSS and Integrated CDSS for the Years 2012, 2020 &
2027

Table 46: USA Current & Future Analysis for Clinical Decision
Support Systems by Application - Conventional CDSS and Advanced
CDSS - Independent Analysis of Annual Sales in US$ Thousand for
the Years 2020 through 2027 and % CAGR

Table 47: USA Historic Review for Clinical Decision Support
Systems by Application - Conventional CDSS and Advanced CDSS
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 48: USA 15-Year Perspective for Clinical Decision Support
Systems by Application - Percentage Breakdown of Value Sales
for Conventional CDSS and Advanced CDSS for the Years 2012,
2020 & 2027

Table 49: USA Current & Future Analysis for Clinical Decision
Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 50: USA Historic Review for Clinical Decision Support
Systems by Type - Therapeutic CDSS and Diagnostic CDSS Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 51: USA 15-Year Perspective for Clinical Decision Support
Systems by Type - Percentage Breakdown of Value Sales for
Therapeutic CDSS and Diagnostic CDSS for the Years 2012, 2020 &
2027

CANADA
Table 52: Canada Current & Future Analysis for Clinical
Decision Support Systems by Component - Hardware, Software and
Services - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 53: Canada Historic Review for Clinical Decision Support
Systems by Component - Hardware, Software and Services Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 54: Canada 15-Year Perspective for Clinical Decision
Support Systems by Component - Percentage Breakdown of Value
Sales for Hardware, Software and Services for the Years 2012,
2020 & 2027

Table 55: Canada Current & Future Analysis for Clinical
Decision Support Systems by Delivery mode - Cloud-based and
On-premise - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 56: Canada Historic Review for Clinical Decision Support
Systems by Delivery mode - Cloud-based and On-premise Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 57: Canada 15-Year Perspective for Clinical Decision
Support Systems by Delivery mode - Percentage Breakdown of
Value Sales for Cloud-based and On-premise for the Years 2012,
2020 & 2027

Table 58: Canada Current & Future Analysis for Clinical
Decision Support Systems by Product - Standalone CDSS and
Integrated CDSS - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 59: Canada Historic Review for Clinical Decision Support
Systems by Product - Standalone CDSS and Integrated CDSS
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 60: Canada 15-Year Perspective for Clinical Decision
Support Systems by Product - Percentage Breakdown of Value
Sales for Standalone CDSS and Integrated CDSS for the Years
2012, 2020 & 2027

Table 61: Canada Current & Future Analysis for Clinical
Decision Support Systems by Application - Conventional CDSS and
Advanced CDSS - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 62: Canada Historic Review for Clinical Decision Support
Systems by Application - Conventional CDSS and Advanced CDSS
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 63: Canada 15-Year Perspective for Clinical Decision
Support Systems by Application - Percentage Breakdown of Value
Sales for Conventional CDSS and Advanced CDSS for the Years
2012, 2020 & 2027

Table 64: Canada Current & Future Analysis for Clinical
Decision Support Systems by Type - Therapeutic CDSS and
Diagnostic CDSS - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 65: Canada Historic Review for Clinical Decision Support
Systems by Type - Therapeutic CDSS and Diagnostic CDSS Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 66: Canada 15-Year Perspective for Clinical Decision
Support Systems by Type - Percentage Breakdown of Value Sales
for Therapeutic CDSS and Diagnostic CDSS for the Years 2012,
2020 & 2027

JAPAN
Table 67: Japan Current & Future Analysis for Clinical Decision
Support Systems by Component - Hardware, Software and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 68: Japan Historic Review for Clinical Decision Support
Systems by Component - Hardware, Software and Services Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 69: Japan 15-Year Perspective for Clinical Decision
Support Systems by Component - Percentage Breakdown of Value
Sales for Hardware, Software and Services for the Years 2012,
2020 & 2027

Table 70: Japan Current & Future Analysis for Clinical Decision
Support Systems by Delivery mode - Cloud-based and On-premise -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 71: Japan Historic Review for Clinical Decision Support
Systems by Delivery mode - Cloud-based and On-premise Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 72: Japan 15-Year Perspective for Clinical Decision
Support Systems by Delivery mode - Percentage Breakdown of
Value Sales for Cloud-based and On-premise for the Years 2012,
2020 & 2027

Table 73: Japan Current & Future Analysis for Clinical Decision
Support Systems by Product - Standalone CDSS and Integrated
CDSS - Independent Analysis of Annual Sales in US$ Thousand for
the Years 2020 through 2027 and % CAGR

Table 74: Japan Historic Review for Clinical Decision Support
Systems by Product - Standalone CDSS and Integrated CDSS
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 75: Japan 15-Year Perspective for Clinical Decision
Support Systems by Product - Percentage Breakdown of Value
Sales for Standalone CDSS and Integrated CDSS for the Years
2012, 2020 & 2027

Table 76: Japan Current & Future Analysis for Clinical Decision
Support Systems by Application - Conventional CDSS and Advanced
CDSS - Independent Analysis of Annual Sales in US$ Thousand for
the Years 2020 through 2027 and % CAGR

Table 77: Japan Historic Review for Clinical Decision Support
Systems by Application - Conventional CDSS and Advanced CDSS
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 78: Japan 15-Year Perspective for Clinical Decision
Support Systems by Application - Percentage Breakdown of Value
Sales for Conventional CDSS and Advanced CDSS for the Years
2012, 2020 & 2027

Table 79: Japan Current & Future Analysis for Clinical Decision
Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 80: Japan Historic Review for Clinical Decision Support
Systems by Type - Therapeutic CDSS and Diagnostic CDSS Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 81: Japan 15-Year Perspective for Clinical Decision
Support Systems by Type - Percentage Breakdown of Value Sales
for Therapeutic CDSS and Diagnostic CDSS for the Years 2012,
2020 & 2027

CHINA
Table 82: China Current & Future Analysis for Clinical Decision
Support Systems by Component - Hardware, Software and Services -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 83: China Historic Review for Clinical Decision Support
Systems by Component - Hardware, Software and Services Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 84: China 15-Year Perspective for Clinical Decision
Support Systems by Component - Percentage Breakdown of Value
Sales for Hardware, Software and Services for the Years 2012,
2020 & 2027

Table 85: China Current & Future Analysis for Clinical Decision
Support Systems by Delivery mode - Cloud-based and On-premise -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 86: China Historic Review for Clinical Decision Support
Systems by Delivery mode - Cloud-based and On-premise Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 87: China 15-Year Perspective for Clinical Decision
Support Systems by Delivery mode - Percentage Breakdown of
Value Sales for Cloud-based and On-premise for the Years 2012,
2020 & 2027

Table 88: China Current & Future Analysis for Clinical Decision
Support Systems by Product - Standalone CDSS and Integrated
CDSS - Independent Analysis of Annual Sales in US$ Thousand for
the Years 2020 through 2027 and % CAGR

Table 89: China Historic Review for Clinical Decision Support
Systems by Product - Standalone CDSS and Integrated CDSS
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 90: China 15-Year Perspective for Clinical Decision
Support Systems by Product - Percentage Breakdown of Value
Sales for Standalone CDSS and Integrated CDSS for the Years
2012, 2020 & 2027

Table 91: China Current & Future Analysis for Clinical Decision
Support Systems by Application - Conventional CDSS and Advanced
CDSS - Independent Analysis of Annual Sales in US$ Thousand for
the Years 2020 through 2027 and % CAGR

Table 92: China Historic Review for Clinical Decision Support
Systems by Application - Conventional CDSS and Advanced CDSS
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 93: China 15-Year Perspective for Clinical Decision
Support Systems by Application - Percentage Breakdown of Value
Sales for Conventional CDSS and Advanced CDSS for the Years
2012, 2020 & 2027

Table 94: China Current & Future Analysis for Clinical Decision
Support Systems by Type - Therapeutic CDSS and Diagnostic CDSS -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 95: China Historic Review for Clinical Decision Support
Systems by Type - Therapeutic CDSS and Diagnostic CDSS Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 96: China 15-Year Perspective for Clinical Decision
Support Systems by Type - Percentage Breakdown of Value Sales
for Therapeutic CDSS and Diagnostic CDSS for the Years 2012,
2020 & 2027

EUROPE
Table 97: Europe Current & Future Analysis for Clinical
Decision Support Systems by Geographic Region - France,
Germany, Italy, UK and Rest of Europe Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 98: Europe Historic Review for Clinical Decision Support
Systems by Geographic Region - France, Germany, Italy, UK and
Rest of Europe Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 99: Europe 15-Year Perspective for Clinical Decision
Support Systems by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK and Rest of Europe
Markets for Years 2012, 2020 & 2027

Table 100: Europe Current & Future Analysis for Clinical
Decision Support Systems by Component - Hardware, Software and
Services - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 101: Europe Historic Review for Clinical Decision Support
Systems by Component - Hardware, Software and Services Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 102: Europe 15-Year Perspective for Clinical Decision
Support Systems by Component - Percentage Breakdown of Value
Sales for Hardware, Software and Services for the Years 2012,
2020 & 2027

Table 103: Europe Current & Future Analysis for Clinical
Decision Support Systems by Delivery mode - Cloud-based and
On-premise - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 104: Europe Historic Review for Clinical Decision Support
Systems by Delivery mode - Cloud-based and On-premise Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 105: Europe 15-Year Perspective for Clinical Decision
Support Systems by Delivery mode - Percentage Breakdown of
Value Sales for Cloud-based and On-premise for the Years 2012,
2020 & 2027

Table 106: Europe Current & Future Analysis for Clinical
Decision Support Systems by Product - Standalone CDSS and
Integrated CDSS - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 107: Europe Historic Review for Clinical Decision Support
Systems by Product - Standalone CDSS and Integrated CDSS
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 108: Europe 15-Year Perspective for Clinical Decision
Support Systems by Product - Percentage Breakdown of Value
Sales for Standalone CDSS and Integrated CDSS for the Years
2012, 2020 & 2027

Table 109: Europe Current & Future Analysis for Clinical
Decision Support Systems by Application - Conventional CDSS and
Advanced CDSS - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 110: Europe Historic Review for Clinical Decision Support
Systems by Application - Conventional CDSS and Advanced CDSS
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 111: Europe 15-Year Perspective for Clinical Decision
Support Systems by Application - Percentage Breakdown of Value
Sales for Conventional CDSS and Advanced CDSS for the Years
2012, 2020 & 2027

Table 112: Europe Current & Future Analysis for Clinical
Decision Support Systems by Type - Therapeutic CDSS and
Diagnostic CDSS - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 113: Europe Historic Review for Clinical Decision Support
Systems by Type - Therapeutic CDSS and Diagnostic CDSS Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 114: Europe 15-Year Perspective for Clinical Decision
Support Systems by Type - Percentage Breakdown of Value Sales
for Therapeutic CDSS and Diagnostic CDSS for the Years 2012,
2020 & 2027

FRANCE
Table 115: France Current & Future Analysis for Clinical
Decision Support Systems by Component - Hardware, Software and
Services - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 116: France Historic Review for Clinical Decision Support
Systems by Component - Hardware, Software and Services Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 117: France 15-Year Perspective for Clinical Decision
Support Systems by Component - Percentage Breakdown of Value
Sales for Hardware, Software and Services for the Years 2012,
2020 & 2027

Table 118: France Current & Future Analysis for Clinical
Decision Support Systems by Delivery mode - Cloud-based and
On-premise - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 119: France Historic Review for Clinical Decision Support
Systems by Delivery mode - Cloud-based and On-premise Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 120: France 15-Year Perspective for Clinical Decision
Support Systems by Delivery mode - Percentage Breakdown of
Value Sales for Cloud-based and On-premise for the Years 2012,
2020 & 2027

Table 121: France Current & Future Analysis for Clinical
Decision Support Systems by Product - Standalone CDSS and
Integrated CDSS - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 122: France Historic Review for Clinical Decision Support
Systems by Product - Standalone CDSS and Integrated CDSS
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 123: France 15-Year Perspective for Clinical Decision
Support Systems by Product - Percentage Breakdown of Value
Sales for Standalone CDSS and Integrated CDSS for the Years
2012, 2020 & 2027

Table 124: France Current & Future Analysis for Clinical
Decision Support Systems by Application - Conventional CDSS and
Advanced CDSS - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 125: France Historic Review for Clinical Decision Support
Systems by Application - Conventional CDSS and Advanced CDSS
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 126: France 15-Year Perspective for Clinical Decision
Support Systems by Application - Percentage Breakdown of Value
Sales for Conventional CDSS and Advanced CDSS for the Years
2012, 2020 & 2027

Table 127: France Current & Future Analysis for Clinical
Decision Support Systems by Type - Therapeutic CDSS and
Diagnostic CDSS - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 128: France Historic Review for Clinical Decision Support
Systems by Type - Therapeutic CDSS and Diagnostic CDSS Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 129: France 15-Year Perspective for Clinical Decision
Support Systems by Type - Percentage Breakdown of Value Sales
for Therapeutic CDSS and Diagnostic CDSS for the Years 2012,
2020 & 2027

GERMANY
Table 130: Germany Current & Future Analysis for Clinical
Decision Support Systems by Component - Hardware, Software and
Services - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 131: Germany Historic Review for Clinical Decision
Support Systems by Component - Hardware, Software and Services
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 132: Germany 15-Year Perspective for Clinical Decision
Support Systems by Component - Percentage Breakdown of Value
Sales for Hardware, Software and Services for the Years 2012,
2020 & 2027

Table 133: Germany Current & Future Analysis for Clinical
Decision Support Systems by Delivery mode - Cloud-based and
On-premise - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 134: Germany Historic Review for Clinical Decision
Support Systems by Delivery mode - Cloud-based and On-premise
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 135: Germany 15-Year Perspective for Clinical Decision
Support Systems by Delivery mode - Percentage Breakdown of
Value Sales for Cloud-based and On-premise for the Years 2012,
2020 & 2027

Table 136: Germany Current & Future Analysis for Clinical
Decision Support Systems by Product - Standalone CDSS and
Integrated CDSS - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 137: Germany Historic Review for Clinical Decision
Support Systems by Product - Standalone CDSS and Integrated
CDSS Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 138: Germany 15-Year Perspective for Clinical Decision
Support Systems by Product - Percentage Breakdown of Value
Sales for Standalone CDSS and Integrated CDSS for the Years
2012, 2020 & 2027

Table 139: Germany Current & Future Analysis for Clinical
Decision Support Systems by Application - Conventional CDSS and
Advanced CDSS - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 140: Germany Historic Review for Clinical Decision
Support Systems by Application - Conventional CDSS and Advanced
CDSS Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 141: Germany 15-Year Perspective for Clinical Decision
Support Systems by Application - Percentage Breakdown of Value
Sales for Conventional CDSS and Advanced CDSS for the Years
2012, 2020 & 2027

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06040513/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001